Innovative sleep apnea testing and treatment solutions

Sleep apnea, which causes temporary pauses in breathing during sleep, is a serious medical condition that can prevent you from getting a good night's rest, and it may lead to other health issues. Testing and treatment products from ZOLL® can help.

GET TO THE HEART OF THE MATTER WITH ZOLL SOLUTIONS

ZOLL offers best-in-class solutions for sleep apnea diagnosis and treatment. WatchPAT® is an innovative Home Sleep Apnea Test (HSAT) that utilizes the peripheral arterial tonometry signal for sleep apnea diagnosis. The remedē® System is an innovative implantable device that treats adult patients with moderate to severe central sleep apnea.

Do you know the consequences of undiagnosed sleep apnea?

Untreated sleep apnea may increase the risk of high blood pressure, heart attack, stroke, obesity, diabetes, and other medical conditions.1 It may also increase the risk of heart failure or worsen existing conditions and increase the likelihood of arrhythmias, or irregular heart beats, including atrial fibrillation (AF). Patients with sleep apnea have four times the risk of developing AF.2

Diagnose Sleep Apnea with the WatchPAT Home Sleep Apnea Test (HSAT)

The WatchPAT Home Sleep Apnea Test is simple, accurate, and reliable.

Learn more
WatchPAT Solutions to support home sleep apnea testing

WatchPAT could accelerate the sleep apnea diagnostic pathway, increase efficiencies, and reduce staff workload.

Learn more
Treat central sleep apnea with the remedē® System

Treat central sleep apnea (CSA) without a mask. Our next generation platform — the remedē System — includes a smaller, slimmer, more comfortable implant with extended battery life. It safely and effectively treats moderate to severe CSA in adult patients. The remedē® System is a small, implantable device that activates automatically and restores a more normal breathing pattern, so you can sleep peacefully. This means you’ll have more energy for doing what you love.

Learn more

Sleep apnea information and resources

About Obstructive and Central Sleep Apnea

Sleep apnea is a common disorder in which a patient experiences pauses or shallow breathing while they sleep. There are two main types – Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA) – and a patient can have both.

OSA is caused by a collapse of the airway that occurs during sleep. CSA occurs when the brain fails to send a signal to the body to take a breath. Breathing pauses can occur several times per hour. These repeated pauses prevent the patient from reaching deeper sleep stages, causing poor quality of sleep and stress on the body.

Learn More

WatchPAT Home Sleep Apnea Test

WatchPAT is a revolutionary FDA-cleared home sleep apnea test that uses innovative technologies to detect sleep apnea. Unlike more complicated diagnostic devices, WatchPAT is an easy-to-use, accurate, and reliable home sleep apnea test (HSAT).

WatchPAT was designed with patient use in mind for “in-home” sleep apnea testing in the comfort of your own bedroom. This environment is more representative of your sleep habits. The WatchPAT home sleep device’s simple operation, and robust noninvasive design, ensure the best possible sleep experience.

Learn More

remedē System, Transphrenic Nerve Stimulation to Treat Central Sleep Apnea

The remedē System is a non-mask therapy designed to treat moderate to severe central sleep apnea in adult patients. remedē is a small, implantable device that activates automatically and restores a more normal breathing pattern. It treats central sleep apnea without a mask or medications.

Learn More

Learn more about sleep apnea testing and management

What is sleep apnea?

Find out more about sleep apnea, its potential impact on your health, and how treatment can help. Home sleep apnea testing with ZOLL products enables you to get started from the comfort of your own bed.

Download brochure

The strong connection between sleep apnea and AFib has been clinically established

WatchPAT has been FDA-cleared to identify AFib events and premature beats.*

Learn More

Sleep apnea management for heart failure patients

Heart failure patients diagnosed and treated for sleep apnea showed an increased survival rate compared to untested patients.3

Learn More

*The WatchPAT® is not intended to be used as a diagnostic device for any cardiac arrhythmia and is not intended to replace traditional methods of diagnosis for cardiac arrhythmias. In cases where the longest AFib episode detected is shorter than 60 seconds, review of the PAT® signal for an irregularly irregular rhythm in the location of the episode is recommended. The WatchPAT® may not detect short AFib episodes (<60 seconds).="">

1 Yeghiazarians Y, Jneid H, Tietjens JR, et al; on behalf of the American Heart Association Council on Clinical Cardiology; Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Stroke Council; and Council on Cardiovascular Surgery and Anesthesia. Obstructive sleep apnea and cardiovascular disease: A scientific statement from the American Heart Association. Circulation;2021;144(3):e56-e67. doi:10.1161/CIR.0000000000000988.

2 Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S, & Sleep Heart Health Study (2006). Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. American journal of respiratory and critical care medicine, 173(8),910-916.

3 Javaheri S, Caref EB, Chen Er, et al. Sleep Apnea Testing in Outcomes in a Large Cohort of Medicare Beneficiaries with Newly Diagnosed Heart Failure.American Journal of Respiratory and Critical Care Medicine, 183(4), 539–546. https://doi.org/10.1164/rccm.201003-0406OC

In sleep apnea management, we're here for you every step of the way

We are proud to offer an array of products and services designed to meet the needs of healthcare professionals and their patients.